Skip to main content
. 2019 Aug 30;69(Suppl 2):S105–S113. doi: 10.1093/cid/ciz463

Table 1.

Distribution of Blood Pathogens in the Different Vaccine Periods by Age Group

Pathogen by Age Group Pathogens, No. (%) OR for Post-PCV vs Pre-PCV Periods 95% CI Change in Post-PCV vs Pre-PCV Periods, % P Value
Total. Pre-PCV Period PCV Introduction Post-PCV Period
All age groups 972 494 126 352
 Streptococcus pneumoniae 242 160 (32.4) 24 (19.0) 58 (16.5) 0.41 .29–.58 −15.9 <.001
 Staphylococcus aureus 214 87 (16.9) 31 (23.4) 96 (27.2) 1.75 1.26–2.44 10.3 <.001
 Escherichia coli 106 55 (11.1) 12 (9.5) 39 (11.1) 0.99 .64–1.54 0.0 .98
NTS 97 61 (12.3) 8 (6.3) 28 (8.0) 0.61 .38–.98 −4.3 .04
Other gram-negative bacteria 73 30 (6.1) 7 (5.6) 36 (10.2) 1.76 1.06–2.92 4.1 .03
Other gram-positive bacteria 58 14 (2.8) 18 (14.3) 26 (7.4) 2.73 1.41–5.32 4.6 .002
 Klebsiella spp. 46 20 (4.0) 5 (4.0) 21 (6.0) 1.50 .80–2.82 2.0 .20
 Pseudomonas spp. 33 25 (5.1) 4 (3.2) 4 (1.1) 0.22 .07–.63 −4.0 <.001
 Haemophilus influenzae non– type b 32 9 (1.8) 8 (6.3) 15 (4.3) 2.40 1.04–5.55 2.5 .04
GAS 20 14 (2.8) 1 (0.8) 5 (1.4) 0.49 .18–1.38 −1.4 .16
 Neisseria meningitidis 16 2 (0.4) 1 (0.8) 13 (3.7) 9.43 2.12– 42.07 3.3 <.001
 Salmonella Typhi 16 9 (1.8) 4 (3.2) 3 (0.9) 0.46 .12–1.72 −0.9 .23
 H. influenzae type b 12 5 (1.0) 1 (0.8) 6 (1.7) 1.70 .51–5.60 0.7 .38
GBS 7 3 (0.6) 2 (1.6) 2 (0.6) 0.94 .16–5.63 0.0 .94
2–23 mo 332 173 39 120
 S. aureus 92 38 (22.0) 11 (28.2) 43 (35.8) 1.98 1.18–3.33 13.8 .009
 S. pneumoniae 81 57 (32.9) 7 (17.9) 17 (14.2) 0.34 .18–.61 −18.7 <.001
NTS 26 15 (8.7) 4 (10.3) 7 (5.8) 0.65 .26–1.65 −2.9 .36
 E. coli 26 14 (8.1) 1 (2.6) 11 (9.2) 1.15 .50–2.62 1.1 .75
 H. influenzae non–type b 21 5 (2.9) 7 (17.9) 9 (7.5) 2.72 .89–8.34 4.6 .07
Other gram-negative bacteria 19 5 (2.9) 2 (5.1) 12 (10.0) 3.73 1.28–10.89 7.1 .01
Other gram-positive bacteria 17 10 (5.8) 1 (2.6) 6 (5.0) 0.86 .30–2.43 −0.8 .77
 Klebsiella spp. 16 8 (4.6) 2 (5.1) 6 (5.0) 1.09 .37–3.21 0.4 .88
 Pseudomonas spp. 10 8 (4.6) 1 (2.6) 1 (0.8) 0.17 .02–1.40 −3.8 .12
GAS 9 7 (4.0) 0 (0) 2 (1.7) 0.40 .08–1.97 −2.3 .23
 H. influenzae type b 6 3 (1.7) 1 (2.6) 2 (1.7) 0.96 .16–5.84 0.0 .96
GBS 5 2 (1.2) 1 (2.6) 2 (1.7) 1.45 .20–10.43 0.5 .71
 N. meningitidis 3 1 (0.6) 0 2 (1.7) 1.06 .26–32.52 1.1 .37
 S. Typhi 1 0 1 (2.6) 0 NA
24–59 mo 145 61 27 57
 S. pneumoniae 41 20 (32.8) 7 (25.9) 14 (24.6) 0.67 .30–1.49 −8.2 .32
 S. aureus 33 10 (16.4) 9 (33.3) 14 (24.6) 1.66 .67–4.11 8.2 .27
NTS 18 10 (16.4) 1 (3.7) 7 (12.3) 0.71 .25–2.02 −4.1 .52
Other gram-positive bacteria 10 2 (3.3) 4 (14.8) 4 (7.0) 2.23 .39–12.65 3.7 .35
 E. coli 8 2 (3.3) 2 (7.4) 4 (7.0) 2.23 .39–12.65 3.7 .35
Other gram-negative bacteria 8 6 (9.8) 1 (3.7) 1 (1.8) 0.16 .02–1.40 −8.0 .05
 N. meningitidis 7 1 (1.6) 1 (3.7) 5 (8.8) 5.77 .64–50.98 7.2 .07
 Klebsiella spp. 6 2 (3.3) 1 (3.7) 3 (5.3) 1.64 .26–10.19 2.0 .59
 H. influenzae non–type b 4 3 (4.9) 0 1 (1.8) 0.35 .03–3.42 −3.1 .33
GAS 4 1 (1.6) 1 (3.7) 2 (3.5) 2.18 .19–24.74 1.9 .52
 Pseudomonas spp. 2 1 (1.6) 0 1 (1.8) 1.07 .07–17.54 0.2 .96
 H. influenzae type b 2 1 (1.6) 0 1 (1.8) 1.07 .07–17.54 0.2 .96
GBS 1 1 (1.6) 0 0 1.00 1.00–1.00 NA
 S. Typhi 1 1 (1.6) 0 0 1.00 1.00–1.00 NA
5–14 y 127 45 23 59
 S. aureus 42 13 (28.9) 6 (26.1) 23 (39.0) 1.57 .69–3.61 10.1 .28
 S. pneumoniae 24 13 (28.9) 3 (13.0) 8 (13.6) 0.39 .14–1.03 −15.3 .054
Other gram-negative bacteria 14 5 (11.1) 3 (13.0) 6 (10.2) 0.91 .26–3.18 −0.9 .88
NTS 11 6 (13.3) 2 (8.7) 3 (5.1) 0.35 .08–1.48 −8.2 .14
Other gram-positive bacteria 9 0 5 (21.7) 4 (6.8) 1.00 1.00–1.00 NA NA
 S. Typhi 6 3 (6.7) 2 (8.7) 1 (1.7) 0.24 .02–2.40 −5.0 .19
 E. coli 5 0 1 (4.3) 4 (6.8) 1.00 1.00–1.00 NA
 Klebsiella spp. 4 2 (4.4) 0 2 (3.4) 0.75 .10–5.57 −1.0 .78
 Pseudomonas spp. 4 2 (4.4) 1 (4.3) 1 (1.7) 0.37 .03–4.22 −2.7 .42
 N. meningitidis 4 0 0 4 (6.8) 1.00 1.00–1.00 NA
 H. influenzae non–type b 3 0 0 3 (5.1) 1.00 1.00–1.00 NA
 H. influenzae type b 1 1 (2.2) 0 0 1.00 1.00–1.00 NA
GAS 0 0 0 0 NA NA NA NA
GBS 0 0 0 0 NA NA NA NA
≥15 y 359 210 36 113
 S. pneumoniae 93 69 (32.9) 6 (16.7) 18 (15.9) 0.39 .22–.69 −17.0 <.001
 E. coli 66 38 (18.1) 8 (22.2) 20 (17.7) 0.97 .54–1.77 −0.4 .93
 S. aureus 47 26 (12.4) 5 (13.9) 16 (14.2) 1.17 .60–2.28 1.8 .65
NTS 42 30 (14.3) 1 (2.8) 11 (9.7) 0.65 .31–1.35 −4.6 .23
Other gram-negative bacteria 30 12 (5.7) 1 (2.8) 17 (15.0) 2.92 1.34–6.36 9.3 .006
Other gram-positive bacteria 22 2 (1.0) 8 (22.2) 12 (10.6) 10.94 2.38– 50.33 9.6 <.001
 Klebsiella spp. 18 7 (3.3) 2 (5.6) 9 (8.0) 2.51 .91–6.93 4.7 .08
 Pseudomonas spp. 17 14 (6.7) 2 (5.6) 1 (0.9) 0.12 .02–.96 −5.8 .008
 S. Typhi 8 5 (2.4) 1 (2.8) 2 (1.8) 0.74 .14–3.87 −0.6 .72
GAS 7 6 (2.9) 0 1 (0.9) 0.30 .04–2.55 −2.0 .21
 H. influenzae non–type b 3 1 (0.5) 1 (2.8) 1 (0.9) 1.87 .12–.12 0.4 .66
 H. influenzae type b 3 0 0 3 (2.7) 1.00 1.00–1.00 NA
 N. meningitidis 2 0 0 2 (1.8) 1.00 1.00–1.00 NA
GBS 1 0 1 (2.8) 0 NA

Abbreviations: CI, confidence interval; GAS, group A streptococci; GBS, group B streptococci; NA, not available; NTS, nontyphoidal Salmonella; OR, odds ratio; PCV, pneumococcal conjugate vaccine.